semaglutide with kidney disease clinicaltrials #medicalresearch FDA Approves Semaglutide to Reduce

La nueva generacin de tratamientos contra la diabetes y la obesidad, que aumentan la accin de una hormona para actuar sobre la secrecin de insulina (GLP-1, pptido similar al glucagn tipo 1) y la sensacin de saciedad, est haciendo furor

For medical use under professional supervision

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds

Easy to drink and delightfully flavourful, it's a beloved choice that satisfies cravings and warms the soul with every sip

Sciarretta S, Forte M, Frati G, Sadoshima J

Collectively, human data suggest that inadvertent early pregnancy exposure does not significantly increase teratogenic risk